Skip to main content

Lorazepam Tablets Shortage

Last Updated: June 24, 2025
Status: Current

Products Affected - Description
    • Ativan tablet, Bausch Health, 1 mg, bottle, 100 count, NDC 00187-0064-01
    • Lorazepam tablet, Major, 0.5 mg, bottle, 100 count, NDC 00904-6007-60 - discontinued
    • Lorazepam tablet, Major, 0.5 mg, unit-dose blister pack, 100 count, NDC 00904-6007-61 - discontinued
    • Lorazepam tablet, Major, 1 mg, bottle, 100 count, NDC 00904-6008-60 - discontinued
    • Lorazepam tablet, Major, 1 mg, unit-dose blister pack, 100 count, NDC 00904-6008-61
    • Lorazepam tablet, Major, 2 mg, bottle, 100 count, NDC 00904-6009-60 - discontinued
    • Lorazepam tablet, Major, 2 mg, unit-dose blister pack, 100 count, NDC 00904-6009-61 - discontinued
    • Lorazepam tablet, Teva, 0.5 mg, bottle, 100 count, NDC 00093-3425-01
    • Lorazepam tablet, Teva, 1 mg, bottle, 100 count, NDC 00093-3426-01
    • Lorazepam tablet, Teva, 2 mg, bottle, 100 count, NDC 00093-3427-01
Reason for the Shortage
    • Aurobindo refuses to provide availability information.
    • Bausch Health did not provide a reason for the shortage.
    • Chartwell has lorazepam tablets available.
    • Leading has lorazepam tablets available.
    • Major has discontinued most lorazepam tablet products.
    • Teva did not provide a reason for the shortage.
Available Products
    • Ativan tablet, Bausch Health, 0.5 mg, bottle, 100 count, NDC 00187-0063-01
    • Ativan tablet, Bausch Health, 1 mg, bottle, 1000 count, NDC 00187-0064-10
    • Ativan tablet, Bausch Health, 2 mg, bottle, 100 count, NDC 00187-0065-01
    • Lorazepam tablet, Chartwell, 0.5 mg, bottle, 100 count, NDC 62135-0861-01
    • Lorazepam tablet, Chartwell, 1 mg, bottle, 100 count, NDC 62135-0862-01
    • Lorazepam tablet, Chartwell, 2 mg, bottle, 100 count, NDC 62135-0863-01
    • Lorazepam tablet, Leading, 0.5 mg, bottle, 100 count, NDC 69315-0904-01
    • Lorazepam tablet, Leading, 0.5 mg, bottle, 500 count, NDC 69315-0904-05
    • Lorazepam tablet, Leading, 0.5 mg, bottle, 1000 count, NDC 69315-0904-10
    • Lorazepam tablet, Leading, 1 mg, bottle, 100 count, NDC 69315-0905-01
    • Lorazepam tablet, Leading, 1 mg, bottle, 500 count, NDC 69315-0905-05
    • Lorazepam tablet, Leading, 1 mg, bottle, 1000 count, NDC 69315-0905-10
    • Lorazepam tablet, Leading, 2 mg, bottle, 100 count, NDC 69315-0906-01
    • Lorazepam tablet, Leading, 2 mg, bottle, 500 count, NDC 69315-0906-05
    • Lorazepam tablet, Leading, 2 mg, bottle, 1000 count, NDC 69315-0906-10
    • Lorazepam tablet, Teva, 0.5 mg, bottle, 500 count, NDC 00093-3425-05
    • Lorazepam tablet, Teva, 0.5 mg, bottle, 1000 count, NDC 00093-3425-10
    • Lorazepam tablet, Teva, 1 mg, bottle, 500 count, NDC 00093-3426-05
    • Lorazepam tablet, Teva, 1 mg, bottle, 1000 count, NDC 00093-3426-10
    • Lorazepam tablet, Teva, 2 mg, bottle, 500 count, NDC 00093-3427-05
    • Lorazepam tablet, Teva, 2 mg, bottle, 1000 count, NDC 00093-3427-10

Estimated Resupply Dates

    • Bausch Health has Ativan 1 mg tablets in 1,000 count on back order and the company cannot estimate a release date.
    • Major has lorazepam 1 mg tablets in 100 count unit-dose packs on back order and the company cannot estimate a release date.
    • Teva has lorazepam 0.5 mg tablets in 100 count bottles, 1 mg tablets in 100 count bottles, and 2 mg tablets in 100 count bottles on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated June 24, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created October 4, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer